Chimerix Inc logo

Chimerix Inc Share Price CMRX

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 17 Apr 2025

Check the interactive Chimerix Inc Stock chart to analyse performance

Chimerix Inc Key Stats

Check Chimerix Inc key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.0
Open
$8.55
Market Capitalization
$801.1M
Today's Volume
$755.4K
Revenue TTM
$212.0K
EBITDA
$-96.5M
Earnings Per Share (EPS)
$-0.99
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-56.17%

Global Institutional Holdings in Chimerix Inc

  • Name

    Holdings %

  • RA Capital Management, LLC

    9.46%

  • Vanguard Group Inc

    4.35%

  • Deerfield Management Co

    4.05%

  • Rosalind Advisors, Inc.

    3.28%

  • Monaco Asset Management

    3.03%

  • Millennium Management LLC

    2.75%

Analyst Recommendation on Chimerix Inc Stock

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Chimerix Inc(by analysts ranked 0 to 5 stars)

About Chimerix Inc

Chimerix, Inc., a biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases in the United States. Its product pipeline comprising dordaviprone (ONC201), which is in phase 3 clinical-stage development for H3 K27M-mutant diffuse glioma, as well as in phase 2 Investigator Initiated Clinical Trials for multiple oncology studies; and ONC206, a second generation imipridone ClpP agonist and DRD2 antagonist which is in phase 1 clinical trial to treat central nervous systems and other solid tumors. The company also develops ONC212, an imipridone, investigational agonist of the orphan GPCR tumor suppressor GPR132, as well as ClpP, which is in preclinical trial; and CMX521, a nucleoside analog antiviral drug candidate for the treatment of novel coronaviruses. In addition, it offers TEMBEXA, a lipid conjugate which acts via inhibition of viral DNA synthesis that is a medical countermeasure for smallpox. The company has license agreement with SymBio Pharmaceuticals to develop and commercialize TEMBEXA for human diseases other than orthopoxviruses, including smallpox. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.
Organization
Chimerix Inc
Employees
79
CEO
Mr. Michael T. Andriole M.B.A.
Industry
Health Technology

Key Management of Chimerix Inc

NameTitle
Mr. Michael T. Andriole M.B.A.
CEO, President & Director
Dr. Michael A. Alrutz J.D., Ph.D.
Senior VP, General Counsel & Corporate Secretary
Dr. Allen S. Melemed M.B.A., M.D.
Chief Medical Officer
Ms. Michelle LaSpaluto
Chief Financial Officer
Mr. Thomas J. Riga
Chief Operating & Commercial Officer
Dr. Roy W. Ware M.B.A., Ph.D.
Chief Manufacturing & Technology Officer
Dr. Joshua E. Allen Ph.D.
Chief Scientific Officer

Important FAQs about investing in CMRX Stock from India :

What is Chimerix Inc share price today?

Chimerix Inc share price today is $0.00 as on at the close of the market. Chimerix Inc share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Chimerix Inc share?

Chimerix Inc share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Chimerix Inc stock price today i.e. is closed at $0.00, lower by 100% versus the 52 week high.

How to invest in Chimerix Inc Stock (CMRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Chimerix Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Chimerix Inc Shares .

What is the minimum amount required to buy Chimerix Inc Stock (CMRX) from India?

Indian investors can start investing in Chimerix Inc (CMRX) shares with as little as ₹94.42 or $1 (as of June 22, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹944.20 in Chimerix Inc stock (as per the Rupee-Dollar exchange rate as on June 22, 2026). Learn more about fractional shares .

What are the returns that Chimerix Inc has given to Indian investors in the last 5 years?

Chimerix Inc stock has given 0.0% share price returns and 27.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?